3.19
-0.08(-2.45%)
Currency In USD
Previous Close | 3.27 |
Open | 3.25 |
Day High | 3.25 |
Day Low | 3.17 |
52-Week High | 4.71 |
52-Week Low | 0.61 |
Volume | 3.03M |
Average Volume | 7.07M |
Market Cap | 1.6B |
PE | -16.79 |
EPS | -0.19 |
Moving Average 50 Days | 3.58 |
Moving Average 200 Days | 2.13 |
Change | -0.08 |
If you invested $1000 in Clover Health Investments, Corp. (CLOV) since IPO date, it would be worth $312.75 as of December 26, 2024 at a share price of $3.19. Whereas If you bought $1000 worth of Clover Health Investments, Corp. (CLOV) shares 3 years ago, it would be worth $787.65 as of December 26, 2024 at a share price of $3.19.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Clover Health to Participate in Upcoming 43rd Annual J.P. Morgan Healthcare Conference
GlobeNewswire Inc.
Dec 17, 2024 9:05 PM GMT
JERSEY CITY, N.J., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Remote-First Company -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that its Chief Executive Officer, Andrew Toy, will present at
Clover Health Reports Strong Third Quarter 2024 Financial Results; Highlights Differentiated Market Opportunity to Grow Membership
GlobeNewswire Inc.
Nov 06, 2024 9:05 PM GMT
Delivers 9% Total Revenue growth year-to-date compared to prior year period Company improves 2024 year-to-date GAAP Net Loss from Continuing Operations by $117.4 million year-over-year and year-to-date Adjusted EBITDA by $87.2 million year-over-year
Clover Health to Participate in Upcoming Investor Conferences
GlobeNewswire Inc.
Oct 29, 2024 8:05 PM GMT
FRANKLIN, Tenn., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced its participation in the following investor conferences: CFO, Peter Kuipers, will prese